SCYNEXIS
SCYX
#7973
Rank
$0.38 B
Marketcap
$4.84
Share price
30.46%
Change (1 day)
601.45%
Change (1 year)

Operating Margin for SCYNEXIS (SCYX)

Operating Margin as of August 2026 (TTM): -40.94%

According to SCYNEXIS's latest financial reports and stock price the company's current Operating Margin is -40.94%. At the end of 2025 the company had an Operating Margin of -40.95%.

Operating Margin history for SCYNEXIS from 2013 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2025-40.95%-92.45%
2024-542.15%-1180.63%
202350.17%-104.1%
2022-1,223.94%383.89%
2021-252.94%
2019-43,573.55%537.07%
2018-6,839.69%-24.25%
2017-9,029.18%-21.44%
2016-11,493.39%4.19%
2015-11,030.74%1961.39%
2014-535.11%385.62%
2013-110.19%76.61%
2012-62.39%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Galmed Pharmaceuticals
GLMD
-479.93% 1,072.28%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Catalyst Pharmaceuticals
CPRX
49.66%-221.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
-2.05%-94.99%๐Ÿ‡บ๐Ÿ‡ธ USA
KemPharm
KMPH
-400.65% 878.63%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.